Raajit K. Rampal, MD, PhD

Raajit Rampal

I am a hematology-oncology physician who specializes in the treatment of leukemia and myeloproliferative diseases (MPDs). I am dedicated to providing my patients with the best possible care, taking into account the individual needs of each patient and his or her family.

As well, I am an active researcher whose focus is the development of new and innovative approaches to treating MPDs and leukemia. I am working to understand the genetic events that contribute to the development and progression of leukemia and MPDs in the hope of developing new targeted therapies for patients with these diseases. I am also studying the thrombotic events that can occur in patients with MPDs in order to understand why they occur, and how to treat and prevent them. Through these efforts, I am committed to improving outcomes for patients with these diseases.

Location

New York City

Appointments for New Patients

212-639-5279

Phone

212-639-2194

Clinical Expertise

Myeloproliferative Neoplasms; Acute and Chronic Leukemia; Myelodysplastic Syndrome

Languages Spoken

English

Education

MD, PhD Molecular and Cellular Biology, Stony Brook University

Residencies

University of Chicago Hospitals

Fellowships

Memorial Sloan-Kettering Cancer Center

Board Certifications

Internal Medicine

See My Colleagues in:

Department of Medicine›Leukemia Service

Clinical Trials Led by Raajit K. Rampal

A Phase II Study of AUY922 in Patients with Myelofibrosis

Clinical Trials Co-Investigated by Raajit K. Rampal

A Phase II Study to Determine if Patients with Chronic Myelogenous Leukemia Who Respond Well to Nilotinib Can Stop Taking this Drug

Publications by Raajit K. Rampal

Visit PubMed for full listing of Raajit K. Rampal journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Topics Recommended by Raajit K. Rampal

Pressroom: $50,000 In Research Funds To Go To Memorial Sloan-Kettering Cancer Center To Study Erdheim-Chester Disease

acute (uh-KYOOT)

Symptoms or signs that begin and worsen quickly; not chronic.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

cancer (KAN-ser)

A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

chronic (KRAH-nik)

A disease or condition that persists or progresses over a long period of time.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

genetic (jeh-NEH-tik)

Inherited; having to do with information that is passed from parents to offspring through genes in sperm and egg cells.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

leukemia (loo-KEE-mee-uh)

Cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of blood cells to be produced and enter the bloodstream.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

medicine (MEH-dih-sin)

Refers to the practices and procedures used for the prevention, treatment, or relief of symptoms of a diseases or abnormal conditions. This term may also refer to a legal drug used for the same purpose.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

National Institutes of Health (NA-shuh-nul IN-stih-TOOTS … helth)

A federal agency in the U.S. that conducts biomedical research in its own laboratories; supports the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helps in the training of research investigators; and fosters communication of medical information. Access the National Institutes of Health Web site at . Also called NIH.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

physician (fih-ZIH-shun)

Medical doctor.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

progression (pruh-GREH-shun)

In medicine, the course of a disease, such as cancer, as it becomes worse or spreads in the body.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

syndrome (SIN-drome)

A set of symptoms or conditions that occur together and suggest the presence of a certain disease or an increased chance of developing the disease.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

View Raajit K. Rampal's laboratory research.